MECOM and pancreatic neoplasm: From in vitro assays, we found that GPC1 committed to cellular proliferation or migration, that EVI1, KRAS and/or miR-96 regulated expression of GPC1, and that EVI1 modulated the oncogenic role of GPC1 in both pancreatic noncancerous cell lines and pancreatic cancer cell lines.